We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-12.61%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$15.4B
AUM Growth
-$2.54B
Cap. Flow
+$226M
Cap. Flow %
1.47%
Top 10 Hldgs %
22.5%
Holding
1,736
New
36
Increased
439
Reduced
483
Closed
127

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.8M
2
AAPL icon
Apple
AAPL
+$42.3M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$38.2M
4
RUN icon
Sunrun
RUN
+$27.6M
5
SEDG icon
SolarEdge
SEDG
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 24.92%
2 Healthcare 21.91%
3 Consumer Discretionary 11.44%
4 Financials 11.29%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBNC icon
1351
First Bancorp
FBNC
$2.74B
$291K ﹤0.01%
8,344
-1,500
-15% -$56K
HOPE icon
1352
Hope Bancorp
HOPE
$1.85B
$290K ﹤0.01%
20,969
-10,300
-33% -$150K
INVA icon
1353
Innoviva
INVA
$1.5B
$290K ﹤0.01%
19,676
-1,000
-5% -$16.4K
PGNY icon
1354
Progyny
PGNY
$1.99B
$290K ﹤0.01%
10,000
DIN icon
1355
Dine Brands
DIN
$440M
$286K ﹤0.01%
4,400
CRTO icon
1356
Criteo S.A. Ordinary Shares
CRTO
$915M
$285K ﹤0.01%
11,700
SI
1357
DELISTED
Silvergate Capital Corporation
SI
$284K ﹤0.01%
5,300
OSH
1358
DELISTED
Oak Street Health, Inc.
OSH
$284K ﹤0.01%
17,300
ALGM icon
1359
Allegro MicroSystems
ALGM
$8.23B
$283K ﹤0.01%
13,700
LGND icon
1360
Ligand Pharmaceuticals
LGND
$5.76B
$282K ﹤0.01%
5,062
TNC icon
1361
Tennant Co
TNC
$1.15B
$282K ﹤0.01%
4,765
-700
-13% -$45.2K
NCNO icon
1362
nCino
NCNO
$2.26B
$281K ﹤0.01%
9,100
FLNA
1363
Filana Therapeutics
FLNA
$45.7M
$281K ﹤0.01%
10,000
-200
-2% -$5.05K
EBS icon
1364
Emergent Biosolutions
EBS
$230M
$280K ﹤0.01%
9,009
VIR icon
1365
Vir Biotechnology
VIR
$1.52B
$280K ﹤0.01%
11,000
-800
-7% -$18.7K
AMSF icon
1366
AMERISAFE
AMSF
$504M
$279K ﹤0.01%
5,358
HAIN icon
1367
Hain Celestial
HAIN
$53.9M
$279K ﹤0.01%
11,739
+2,900
+33% +$82.6K
ASTH icon
1368
Astrana Health
ASTH
$1.87B
$278K ﹤0.01%
7,200
+500
+7% +$19K
BATRK icon
1369
Atlanta Braves Holdings Series B
BATRK
$3.41B
$277K ﹤0.01%
11,560
IOVA icon
1370
Iovance Biotherapeutics
IOVA
$2.95B
$275K ﹤0.01%
24,900
ARGO
1371
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$275K ﹤0.01%
7,459
-1,200
-14% -$49.3K
BRKL
1372
DELISTED
Brookline Bancorp
BRKL
$274K ﹤0.01%
20,583
-4,500
-18% -$64.6K
CCS icon
1373
Century Communities
CCS
$2.04B
$274K ﹤0.01%
6,100
-2,200
-27% -$111K
ADAM
1374
Adamas Trust
ADAM
$907M
$274K ﹤0.01%
24,825
ADEA icon
1375
Adeia
ADEA
$3.16B
$273K ﹤0.01%
71,442

Similar funds

Handelsbanken Fonder's Q2 2022 Portfolio in Review

As of Q2 2022, Handelsbanken Fonder held 1,736 positions worth $15.4B, down 14% from $17.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q2 2022 filing shows 36 new, 439 increased, 483 reduced and 127 closed positions. Its largest new stake was Avantor: 226,479 shares worth $7.04M. The largest sale was Amazon, an estimated $307M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q2 2022 buy was Avantor: 226,479 shares worth $7.04M.
  • Handelsbanken Fonder added most to NVIDIA in Q2 2022, an estimated $46.8M increase.
  • Handelsbanken Fonder's biggest Q2 2022 reduction was Amazon, cutting an estimated $307M.
  • Handelsbanken Fonder fully exited Cerence in Q2 2022, selling an estimated $12.9M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $15.4B portfolio in Q2 2022.
  • Handelsbanken Fonder opened 36 new positions and closed 127 in Q2 2022.
  • Handelsbanken Fonder's portfolio value fell 14% quarter-over-quarter to $15.4B.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.